| |
| |
|
| Insider
Information: |
Sinclair Andrew |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,900 |
|
|
Indirect Shares
|
20,137,987 |
|
|
| Direct
Value |
$9,912 |
|
|
|
Indirect Value
|
$6,444,672 |
|
|
| Total
Shares |
20,143,887 |
|
|
| Total
Value |
$6,454,584 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
| Percentage
Gain/Loss : |
 -56.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Soleno Therapeutics Inc |
SLNO |
Director |
2018-12-21 |
0 |
2022-03-29 |
18,022,602 |
Premium* |
|
|
Sierra Oncology Inc |
SRRA |
Director |
|
0 |
2022-07-01 |
0 |
Premium* |
|
|
Adicet Bio, Inc |
ACET |
Director |
2023-06-01 |
5,900 |
2023-06-01 |
2,115,385 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACET |
Adicet Bio, Inc |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,900 |
5,900 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2022-07-01 |
4 |
D |
$55.00 |
$72,276,985 |
I/I |
(1,314,127) |
0 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-29 |
4 |
B |
$0.00 |
$0 |
I/I |
7,720,000 |
18,022,602 |
2.02 |
% |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2022-01-31 |
4 |
B |
$27.00 |
$4,050,000 |
I/I |
150,000 |
1,314,127 |
2.1 |
% |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2022-01-28 |
4 |
OE |
$13.20 |
$3,794,617 |
I/I |
287,471 |
1,164,127 |
0 |
- |
|
| ACET |
Adicet Bio, Inc |
Director |
– • – |
2021-12-08 |
4/A |
B |
$14.00 |
$7,000,000 |
I/I |
500,000 |
2,115,385 |
2.1 |
- |
|
| ACET |
Adicet Bio, Inc |
Director |
– • – |
2021-12-08 |
4 |
B |
$14.00 |
$7,000,000 |
I/I |
500,000 |
2,140,721 |
2.1 |
% |
|
| ACET |
Adicet Bio, Inc |
Director |
– • – |
2021-03-02 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,615,385 |
|
- |
|
| ACET |
Adicet Bio, Inc |
Director |
– • – |
2021-03-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,640,721 |
|
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2020-06-26 |
4 |
B |
$1.65 |
$5,499,995 |
I/I |
3,333,330 |
10,302,602 |
2.1 |
% |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2020-01-29 |
4/A |
A |
$0.00 |
$0 |
I/I |
871,240 |
876,656 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
871,125 |
876,542 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2019-11-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
216,667 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2019-10-25 |
4 |
B |
$1.20 |
$2,760,000 |
I/I |
2,300,000 |
6,969,272 |
2.1 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2018-12-21 |
4 |
B |
$1.60 |
$7,470,835 |
I/I |
4,669,272 |
4,669,272 |
2.1 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
